Multiple Cardiovascular Diseases or Risk Factors Increase the Severity of Coronavirus Disease 2019.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 10 2021
Historique:
pubmed: 25 9 2021
medline: 5 11 2021
entrez: 24 9 2021
Statut: ppublish

Résumé

This study aimed to determine whether disease severity varied according to whether coronavirus disease 2019 (COVID-19) patients had multiple or single cardiovascular diseases and risk factors (CVDRFs).Methods and Results:COVID-19 patients with single (n=281) or multiple (n=412) CVDRFs were included retrospectively. Multivariable logistic regression showed no significant difference in the risk of in-hospital death between groups, but patients with multiple CVDRFs had a significantly higher risk of acute respiratory distress syndrome (odds ratio: 1.75, 95% confidence interval: 1.09-2.81). COVID-19 patients with multiple CVDRFs have a higher risk of complications than those with a single CDVRF.

Sections du résumé

BACKGROUND
This study aimed to determine whether disease severity varied according to whether coronavirus disease 2019 (COVID-19) patients had multiple or single cardiovascular diseases and risk factors (CVDRFs).Methods and Results:COVID-19 patients with single (n=281) or multiple (n=412) CVDRFs were included retrospectively. Multivariable logistic regression showed no significant difference in the risk of in-hospital death between groups, but patients with multiple CVDRFs had a significantly higher risk of acute respiratory distress syndrome (odds ratio: 1.75, 95% confidence interval: 1.09-2.81).
CONCLUSIONS
COVID-19 patients with multiple CVDRFs have a higher risk of complications than those with a single CDVRF.

Identifiants

pubmed: 34556591
doi: 10.1253/circj.CJ-21-0684
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2111-2115

Auteurs

Tomoyuki Yamada (T)

Infection Control Center, Osaka Medical and Pharmaceutical University Hospital.
Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital.

Taku Ogawa (T)

Infection Control Center, Osaka Medical and Pharmaceutical University Hospital.
Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University.

Kenta Minami (K)

Infection Control Center, Osaka Medical and Pharmaceutical University Hospital.

Yusuke Kusaka (Y)

Infection Control Center, Osaka Medical and Pharmaceutical University Hospital.
Department of Anesthesiology, Osaka Medical and Pharmaceutical University.

Masaaki Hoshiga (M)

Department of Cardiology, Osaka Medical and Pharmaceutical University.

Akira Ukimura (A)

Infection Control Center, Osaka Medical and Pharmaceutical University Hospital.
Department of Cardiology, Osaka Medical and Pharmaceutical University.

Takahide Sano (T)

Department of Cardiovascular Medicine, Toho University Graduate School of Medicine.

Takeshi Kitai (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Taishi Yonetsu (T)

Department of Interventional Cardiology, Tokyo Medical and Dental University.

Sho Torii (S)

Department of Cardiology, Tokai University School of Medicine.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine.

Shunsuke Kuroda (S)

Department of Cardiovascular Medicine, Cleveland Clinic.

Koichi Node (K)

Department of Cardiovascular Medicine, Saga University.

Yuya Matsue (Y)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine.

Shingo Matsumoto (S)

Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH